BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27199453)

  • 1. Heterotrimeric G protein signaling in polycystic kidney disease.
    Hama T; Park F
    Physiol Genomics; 2016 Jul; 48(7):429-45. PubMed ID: 27199453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD.
    Parnell SC; Magenheimer BS; Maser RL; Pavlov TS; Havens MA; Hastings ML; Jackson SF; Ward CJ; Peterson KR; Staruschenko A; Calvet JP
    Hum Mol Genet; 2018 Oct; 27(19):3313-3324. PubMed ID: 29931260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Mechanisms of ADPKD.
    Kim DY; Park JH
    Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
    Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
    Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic kidney disease: novel insights into polycystin function.
    Luo L; Roy S; Li L; Ma M
    Trends Mol Med; 2023 Apr; 29(4):268-281. PubMed ID: 36805211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
    Xu Y; Li A; Wu G; Liang C
    Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics and physiology of polycystic kidney disease.
    Calvet JP; Grantham JJ
    Semin Nephrol; 2001 Mar; 21(2):107-23. PubMed ID: 11245774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease.
    Smith AO; Jonassen JA; Preval KM; Davis RJ; Pazour GJ
    PLoS Genet; 2021 Dec; 17(12):e1009711. PubMed ID: 34962918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.
    Arnould T; Sellin L; Benzing T; Tsiokas L; Cohen HT; Kim E; Walz G
    Mol Cell Biol; 1999 May; 19(5):3423-34. PubMed ID: 10207066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative transcriptomics of shear stress treated Pkd1
    Kunnen SJ; Malas TB; Formica C; Leonhard WN; 't Hoen PAC; Peters DJM
    Biomed Pharmacother; 2018 Dec; 108():1123-1134. PubMed ID: 30372813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic Kidney Disease.
    Ghata J; Cowley BD
    Compr Physiol; 2017 Jun; 7(3):945-975. PubMed ID: 28640449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autosomal dominant polycystic kidney disease--research status and clinical manifestation].
    Augustyniak-Bartosik H; Weyde W; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2004; 58():530-7. PubMed ID: 15765015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
    Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
    Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation, protein kinases and ADPKD.
    Li X
    Biochim Biophys Acta; 2011 Oct; 1812(10):1219-24. PubMed ID: 21392577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic kidney disease: a Hippo connection.
    Ma S; Guan KL
    Genes Dev; 2018 Jun; 32(11-12):737-739. PubMed ID: 29921661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of polycystic kidney disease.
    Calvet JP
    J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.